← Back to Events
BIOTECH CONCLUDED
Pharma Partnering US
Join researchers and industry partners—from major pharmaceutical companies and small-mid-size biotech companies—to share early oncology pipelines and innovation strategies for drug development and presents analysts and investors with new partnership and licensing opportunities to advance these concepts.
Coverage & Analysis
7 articlesLIVE COVERAGE
Apr 29
BREAKING Pharma Partnering US: Biotech Dealmaking Heats Up
Apr 29 BREAKING Pharma Partnering US: Biotech Dealmaking Heats Up
Apr 29 BREAKING Pharma Partnering US: Biotech Deals and Investment Trends
Apr 29 BREAKING Pharma Partnering US: Biotech Deals & Investment Trends Day 1
Apr 29 BREAKING Pharma Partnering US: Emergent, EvolveImmune Deals Emerge
🇺🇸 Latest Americas News
All news → May 5 Palvella Therapeutics Begins Phase 2 Trial of QTORIN Rapamycin for Rare Angiokeratomas May 5 Neurocrine Biosciences Begins Phase 1 Trial of NBIP-2118 for Obesity Treatment May 5 CAPLYTA (Lumateperone) Ranks Highest Among FDA-Approved Adjunctive Depression Treatments in Network Meta-Analysis May 5 Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD May 5 Cellenkos Receives FDA Clearance for CK0802 Phase 1b/2a Trial in Steroid-Refractory GVHD